QSAR and Anticancer effect of Alkyl salicylate on Breast cancer T47D Cells Lines

Author:

Divina Elizabeth1,Erlina Linda2,Anbar Istiadi Khaerunissa3,Yasa Putri Elfa Siska4,Fadilah Fadilah5

Affiliation:

1. Faculty of Medicine, University of Indonesia, Salemba Raya 6, Jakarta, Indonesia.

2. Department of Medical Chemistry, Faculty of Medicine, University of Indonesia, Salemba Raya 6, Jakarta, Indonesia.

3. Bioinformatics Core Facilities, IMERI Faculty of Medicine, University of Indonesia, Salemba Raya 6, Jakarta, Indonesia.

4. Faculty of Pharmacy and Science, Muhammadiyah Prof. Dr. Hamka University, Jakarta, Indonesia.

5. Bioinformatics Core Facilities, IMERI Faculty of Medicine, University of Indonesia, Salemba Raya 6, Jakarta, Indonesia.

Abstract

Cancer is a major health concern in both developed and developing countries, second leading cause of mortality worldwide. Among the different types of cancer, breast cancer is the most common cancer found in females worldwide. Studies have shown that salicylic acid decreases cell viability and potentially used in cancer therapy. This research aim is to analyze the cytotoxicity effect of alkylated salicylic acid towards breast cancer cells T47D. Samples used are methyl salicylate, ethyl salicylate, butyl salicylate, isoamyl salicylate, and octyl salicylate. Thin layer chromatography was done to samples and MTT test was done against T47D cancer cells to obtain cancer cell growth and IC50 value. QSAR analysis were carried out to predict the theoretical activity of the alkylated salicylates. Based on MTT result, there was shown an increase of cytotoxicity effect with higher concentration. IC50 value of alkylated salicylic acid showed more significant cytotoxicity effect (p<0,05) when compared to IC50 value of salicylic acid, except octyl salicylate. This shows that addition of alkyl group enhances cytotoxicity effect of salicylic acid due to increase of affinity. The IC50 value of alkylated salicylic acid showed lower results compared to salicylic acid. The QSAR equation is Log (1/IC50) = -1236.21871 - 236.42806 *logP(o/w) -1186.53810 * AM1_LUMO +251.55826* mr ((n = 7 r = 0,94 RMSE = 4,08). The QSAR showed the descriptors which has effect towards inhibition activity of breast cancer cell line are log P, mr, and AM_1LUMO.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Reference40 articles.

1. Organization WH. The Global Cancer Observatory: Indonesia [Internet]. 2019 [cited 2019 Jun 30]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact-sheets.pdf

2. Dange VN, Shid SJ, Magdum CS, Mohite SK. A Review on Breast cancer: An Overview. Asian J Pharm Res. 2017;7(1):49. doi.org/10.5958/2231-5691.2017.00008.9

3. Yadav AR, Mohite SK. Cancer-A silent killer: An overview. Asian J Pharm Res. 2020;10(3):213. doi.org/10.5958/2231-5691.2020.00036.2

4. Sudarshan B, Vikas S, Viveknand C, Vilas S, Suresh R, Ganesh D. Tamoxifen Citrate Loaded Solid Lipid Nanoparticles- A Novel Approach In The Treatment of ER+ Breast Cancer. Res J Pharm Dos Forms Technol. 2009;1(2):143–9.

5. Nazarali SA, Narod SA. Tamoxifen for women at high risk of breast cancer. Breast cancer (Dove Med Press. 2014;6:29–36. doi.org/10.2147/BCTT.S43763

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3